| 申请日期 | 2025-07-14 | 申请号 | KR1020177019687 |
| 公开（公告）号 | KR1020170095352A | 公开（公告）日 | 2017-08-22 |
| 公开国别 | KR | 申请人省市代码 | 全国 |
| 申请人 | GALDERMA RES DEV | ||
| 简介 | Indazole sulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonists of retinoid-related orphan receptor gamma RORγt are described. Pharmaceutical compositions including such compounds, as well as the use thereof for the topical and/or oral treatment of RORγt receptor-mediated inflammatory diseases, in particular acne, psoriasis and/or atopic dermatitis are also described. | ||
|
您还没有登录，请登录后查看下载地址
|
客服热线：
手机版
二维码
